ACC.24 - In the PREVENT trial, preventive PCI plus optimal medical therapy (OMT) was superior to OMT alone for reducing cardiac events in patients with non–flow-limiting vulnerable coronary plaques. Marc Bonaca, the discussant of the PREVENT trial, reviews the results.
Preventive PCI versus only optimal medical therapy for vulnerable plaques
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Preventive PCI versus optimal medical therapy only for vulnerable plaques
Restart
Resume
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Overview
Educational information
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Faculty
Marc Bonaca, MD is a Cardiologist and Vascular Medicine Specialist and is the Executive Director of CPC Clinical Research and CPC Community Health at the University of Colorado, Boulder, CO, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 15 april 2024
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
ACC.24 - In the PREVENT trial, preventive PCI plus optimal medical therapy (OMT) was superior to OMT alone for reducing cardiac events in patients with non–flow-limiting vulnerable coronary plaques. Marc Bonaca, the discussant of the PREVENT trial, reviews the results.
Educational information
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Faculty
Marc Bonaca, MD is a Cardiologist and Vascular Medicine Specialist and is the Executive Director of CPC Clinical Research and CPC Community Health at the University of Colorado, Boulder, CO, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 15 april 2024
Presenters
Facebook Comments